"BioBehavioral Research of Austin provides healthcare services and conducts clinical research in the Austin community. Our physicians have experience in studies Major Depression, ADHD, Autism Spectrum Disorder, Bipolar, Schizophrenia and other CNS related disorders."

During the past decade, BioBehavioral Research of Austin conducted 35 clinical trials. In the 10-year time frame, 35 clinical trials started and 20 clinical trials were completed, i.e. on average, 57.1% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 18 clinical trials were completed. i.e. 138.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "BioBehavioral Research of Austin" #1 sponsor was "Supernus Pharmaceuticals, Inc." with 5 trials, followed by "Hoffmann-La Roche" with 4 trials sponsored, "Sunovion" with 4 trials sponsored, "Naurex, Inc, an affiliate of Allergan plc" with 3 trials sponsored and "Biohaven Pharmaceuticals, Inc." with 3 trials sponsored. Other sponsors include 13 different institutions and companies that sponsored additional 18 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "BioBehavioral Research of Austin" #1 collaborator was "Medpace, Inc." with 1 trials as a collaborator and "Takeda" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "BioBehavioral Research of Austin" are "Major Depressive Disorder" (5 trials), "Autism Spectrum Disorder" (4 trials), "Depressive Disorder, Major" (4 trials), "Attention Deficit Hyperactivity Disorder" (3 trials) and "Attention Deficit Hyperactivity Disorder (ADHD)" (3 trials). Many other conditions were trialed in "BioBehavioral Research of Austin" in a lesser frequency.

Most popular intervention types in "BioBehavioral Research of Austin" are "Drug" (30 trials), "Other" (4 trials), "Biological" (2 trials), "Device" (1 trials) and "Genetic" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (20 trials), "Rapastinel" (3 trials), "Dasotraline" (2 trials), "Fluoxetine" (2 trials) and "SPD489" (2 trials). Other intervention names were less common.

The vast majority of trials in "BioBehavioral Research of Austin" are 36 trials for "All" genders.

Currently, there are 12 active trials in "BioBehavioral Research of Austin". 1 are not yet recruiting, 9 are recruiting, 1 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 20 completed trials in BioBehavioral Research of Austin, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in BioBehavioral Research of Austin, 3 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 23 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 2 trials that are defined as “Not Applicable".